| NO | ಉತ್ಪನ್ನಗಳು | CAS ಸಂಖ್ಯೆ | ಪ್ರಮುಖ ಗುಣಮಟ್ಟ ಸೂಚಕ | |||
| ಶುದ್ಧತೆ | ಗರಿಷ್ಠ. ಅಶುದ್ಧತೆ | ಒಟ್ಟು ದ್ರಾವಕ ಶೇಷ | ತೇವಾಂಶ | |||
| 1 | Fmoc-β-ಅಲಾ-ಅಲಾ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 2 | Fmoc-D-ಅಲಾ-D-ಅಲಾ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 3 | Fmoc-β-ಅಲಾ-ಡಿ-ಅಲಾ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 4 | Fmoc-ಆರ್ಗ್(ಪಿಬಿಎಫ್)-ಆರ್ಗ್(ಪಿಬಿಎಫ್)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 5 | Fmoc-β-ಅಲಾ-ಆರ್ಗ್(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 6 | Fmoc-ಡಿ-ಆರ್ಗ್(ಪಿಬಿಎಫ್)-ಡಿ-ಆರ್ಗ್(ಪಿಬಿಎಫ್)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 7 | Fmoc-β-ಅಲಾ-ಡಿ-ಆರ್ಗ್(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 8 | Fmoc-ಹೋಮೋಆರ್ಗ್(pbf)-ಹೋಮೋಆರ್ಗ್(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 9 | Fmoc-β-ಅಲಾ-ಹೋಮೋಆರ್ಗ್(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 10 | ಎಫ್ಎಂಒಸಿ-ಆಸ್ನ್(ಟಿಆರ್ಟಿ)-ಆಸ್ನ್(ಟಿಆರ್ಟಿ)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 11 | Fmoc-β-ಅಲಾ-Asn(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 12 | Fmoc-Asp(OtBu)-Asp(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 13 | Fmoc-β-ಅಲಾ-ಆಸ್ಪ್(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 14 | Fmoc-ಸಿಸ್(Trt)-ಸಿಸ್(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 15 | Fmoc-β-ಅಲಾ-ಸಿಸ್(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 16 | Fmoc-ಸಿಸ್(Acm)-ಸಿಸ್(Acm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 17 | Fmoc-β-ಅಲಾ-ಸಿಸ್(Acm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 18 | ಎಫ್ಎಂಒಸಿ-ಗ್ಲ್ನ್(ಟಿಆರ್ಟಿ)-ಗ್ಲ್ನ್(ಟಿಆರ್ಟಿ)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 19 | Fmoc-β-ಅಲಾ-ಗ್ಲ್ನ್(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 20 | Fmoc-ಗ್ಲು(OtBu)-ಗ್ಲು(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 21 | Fmoc-β-ಅಲಾ-ಗ್ಲು(OtBu)-OH.H2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 22 | Fmoc-β-ಅಲಾ-ಗ್ಲೈ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 23 | Fmoc-ಅವರ(Trt)-ಅವರ(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 24 | Fmoc-β-ಅಲಾ-ಹಿಸ್(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 25 | Fmoc-ಐಲ್-ಐಲ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 26 | Fmoc-β-ಅಲಾ-ಐಲ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 27 | Fmoc-ಲಿಯು-ಲಿಯು-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 28 | Fmoc-β-ಅಲಾ-ಲಿಯು-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 29 | Fmoc-D-Leu-D-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 30 | Fmoc-β-ಅಲಾ-ಡಿ-ಲಿಯು-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 31 | Fmoc-ಲೈಸ್(ಬಾಕ್)-ಲೈಸ್(ಬಾಕ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 32 | Fmoc-β-ಅಲಾ-ಲೈಸ್(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 33 | Fmoc-ಲೈಸ್(ಅಲೋಕ್)-ಲೈಸ್(ಅಲೋಕ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 34 | Fmoc-β-ಅಲಾ-ಲೈಸ್(ಅಲೋಕ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 35 | Fmoc-ಮೆಟ್-ಮೆಟ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 36 | Fmoc-β-ಅಲಾ-ಮೆಟ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 37 | ಎಫ್ಎಂಒಸಿ-ಓರ್ನ್(ಬಾಕ್)-ಓರ್ನ್(ಬಾಕ್)-ಓಎಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 38 | Fmoc-β-ಅಲಾ-ಓರ್ನ್(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 39 | Fmoc-ಫೆ-ಫೆ-ಓಎಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 40 | Fmoc-β-ಅಲಾ-ಫೆ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 41 | Fmoc-D-Phe-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 42 | Fmoc-β-ಅಲಾ-ಡಿ-ಫೆ-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 43 | Fmoc-ಪ್ರೊ-ಪ್ರೊ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 44 | Fmoc-β-ಅಲಾ-ಪ್ರೊ-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 45 | Fmoc-ಸೆರ್(ಟಿಬಿಯು)-ಸೆರ್(ಟಿಬಿಯು)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 46 | Fmoc-β-ಅಲಾ-ಸೆರ್(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 47 | ಎಫ್ಎಂಒಸಿ-ಸರ್(ಟಿಆರ್ಟಿ)-ಸರ್(ಟಿಆರ್ಟಿ)-ಒಎಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 48 | Fmoc-β-ಅಲಾ-ಸೆರ್(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 49 | Fmoc-Thr(tBu)-Thr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 50 | Fmoc-β-ಅಲಾ-ಥ್ರ(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 51 | Fmoc-Trp(Boc)-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 52 | Fmoc-β-ಅಲಾ-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 53 | Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 54 | Fmoc-β-ಅಲಾ-ಡಿ-ಟಿಆರ್ಪಿ(ಬಾಕ್)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 55 | Fmoc-ಟೈರ್(tBu)-ಟೈರ್(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 56 | Fmoc-β-ಅಲಾ-ಟೈರ್(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 57 | Fmoc-D-ಟೈರ್(Et)-D-ಟೈರ್(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 58 | Fmoc-β-ಅಲಾ-ಡಿ-ಟೈರ್(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 59 | Fmoc-ಟೈರ್(ಮಿ)-ಟೈರ್(ಮಿ)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 60 | Fmoc-β-ಅಲಾ-ಟೈರ್(ಮಿ)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 61 | Fmoc-ವಾಲ್-ವಾಲ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 62 | Fmoc-β-ಅಲಾ-ವಾಲ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 63 | Fmoc-D-Cit-D-Cit-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 64 | Fmoc-β-ಅಲಾ-ಡಿ-ಸಿಟ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 65 | Fmoc-β-ಅಲಾ-ಡಾಬ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 66 | Fmoc-(3-(2-ನಾಫ್ಥೈಲ್)-D-ಅಲಾ)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 67 | Fmoc-β-Ala-3-(2-naphthyl)-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 68 | Fmoc-(3-(3-ಪಿರಿಡಿನೈಲ್)-D-ಅಲಾ)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 69 | Fmoc-β-Ala-3-(3-ಪಿರಿಡಿನೈಲ್)-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 70 | Fmoc-(4-ಕ್ಲೋರೋ-D-Phe)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 71 | Fmoc-β-Ala-4-ಕ್ಲೋರೋ-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 72 | Fmoc-(D-4Aph(tBuCbm))2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 73 | Fmoc-β-ಅಲಾ-D-4Aph(tBuCbm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 74 | Fmoc-ಆಫ್(L-ಹಾರ್)-ಆಫ್(L-ಹಾರ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 75 | Fmoc-β-ಅಲಾ-ಆಫ್(L-ಹೋರ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 76 | Fmoc-ಲೈಸ್(ಐಪಿಆರ್,ಬಾಕ್)-ಲೈಸ್(ಐಪಿಆರ್,ಬಾಕ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 77 | Fmoc-β-ಅಲಾ-ಲೈಸ್(iPr,Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 78 | Fmoc-β-ಅಲಾ-AEEA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 79 | ಎಫ್ಎಂಒಸಿ-ಐಬ್-ಐಬ್-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 80 | Fmoc-β-ಅಲಾ-ಐಬ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 81 | Fmoc-ಆರ್ಗ್-OH | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 82 | ಎಚ್-ಆರ್ಗ್(ಪಿಬಿಎಫ್)-ಒಹೆಚ್ | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 83 | Fmoc-D-Arg-OH | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 84 | HD-ಆರ್ಗ್(pbf)-OH | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 85 | Fmoc-ಹೋಮೋಆರ್ಗ್-OH.HCl | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 86 | ಎಚ್-ಹೋಮೋಆರ್ಗ್(ಪಿಬಿಎಫ್)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 87 | Fmoc-D-ಹೋಮೋಆರ್ಗ್-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 88 | HD-ಹೋಮೋಆರ್ಗ್(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 89 | ಎಫ್ಎಂಒಸಿ-ಆಸ್ನ್-ಒಹೆಚ್ | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 90 | ಎಚ್-ಆಸ್ನ್(ಟಿಆರ್ಟಿ)-ಒಹೆಚ್ | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 91 | ಎಫ್ಎಂಒಸಿ-ಆಸ್ಪ್-ಒಹೆಚ್ | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 92 | ಎಚ್-ಆಸ್ಪ್(ಒಟಿಬಿಯು)-ಒಹೆಚ್ | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 93 | Fmoc-Cys-OH | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 94 | ಎಚ್-ಸಿಸ್(Trt)-OH | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 95 | H-Cys(Acm)-OH.HCl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 96 | ಎಫ್ಎಂಒಸಿ-ಜಿಎಲ್ಎನ್-ಒಹೆಚ್ | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 97 | ಎಚ್-ಗ್ಲಿನ್(Trt)-OH | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 98 | ಎಫ್ಎಂಒಸಿ-ಗ್ಲು-ಒಹೆಚ್ | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 99 | H-ಗ್ಲು(OtBu)-OH.H2O | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 100 (100) | Fmoc-ಹಿಸ್-OH | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 101 (101) | ಎಚ್-ಹಿಸ್(Trt)-OH | 35146-32-8 (ಸಂಪಾದಕ) | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 102 | ಬೊಕ್-ಹಿಸ್-ಒಹೆಚ್ | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 103 | ಎಫ್ಎಂಒಸಿ-ಲೈಸ್-ಒಹೆಚ್ | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 104 (ಅನುವಾದ) | ಎಚ್-ಲೈಸ್(ಬಾಕ್)-OH | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 105 | ಎಚ್-ಲೈಸ್(ಅಲೋಕ್)-OH | 6298/3/9 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 106 | ಎಫ್ಎಂಒಸಿ-ಓರ್ನ್-ಒಹೆಚ್.ಎಚ್ಸಿಎಲ್ | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 107 (107) | ಎಚ್-ಓರ್ನ್(ಬಾಕ್)-ಒಹೆಚ್ | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 108 | ಎಫ್ಎಂಒಸಿ-ಸೆರ್-ಒಹೆಚ್ | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 109 (ಅನುವಾದ) | ಎಚ್-ಸರ್(ಟಿಬಿಯು)-ಒಹೆಚ್ | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 110 (110) | ಎಚ್-ಸರ್(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 111 (111) | Fmoc-Thr-OH.H2O | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 112 | H-Thr(tBu)-OH | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 113 | Fmoc-Trp-OH | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 114 (114) | ಎಚ್-ಟಿಆರ್ಪಿ(ಬಿಒಸಿ)-ಒಹೆಚ್ | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 115 | Fmoc-D-Trp-OH | 86123-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 116 | HD-Trp(Boc)-OH | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 117 (117) | ಎಫ್ಎಂಒಸಿ-ಟೈರ್-ಒಹೆಚ್ | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 118 | ಎಚ್-ಟೈರ್(ಟಿಬಿಯು)-ಒಹೆಚ್ | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 119 (119) | Fmoc-D-ಟೈರ್-OH | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 120 (120) | HD-ಟೈರ್(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 121 (121) | ಎಚ್-ಟೈರ್(ಮಿ)-ಒಹೆಚ್.ಎಚ್ಸಿಎಲ್ | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 122 (122) | Fmoc-D-4Aph(Cbm)-OH | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 123 | HD-4Aph(tBuCbm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 124 (124) | Fmoc-ಲೈಸ್(ಐಪಿಆರ್)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
| 125 | ಎಚ್-ಲೈಸ್(ಐಪಿಆರ್,ಬಾಕ್)-ಒಹೆಚ್ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
ಪರಿಹಾರ
ಜೆಂಟೊಲೆಕ್ಸ್ ಉತ್ತಮ ಗುಣಮಟ್ಟದ ಉತ್ಪನ್ನಗಳನ್ನು ಒದಗಿಸುತ್ತದೆ, ಯಾವುದೇ ಉತ್ಪನ್ನದ ಗುಣಮಟ್ಟವನ್ನು ಗ್ರಾಹಕರು ಅಗತ್ಯ ಸಮಯದೊಳಗೆ ಸಾಕಷ್ಟು ಪುರಾವೆಗಳೊಂದಿಗೆ ಹೆಚ್ಚಿಸಿದರೆ, ಪರಿಹಾರದ ಕಾರ್ಯವಿಧಾನಗಳನ್ನು ಪ್ರಾರಂಭಿಸಲು ನಾವು ಅಗತ್ಯವಾದ ವಿಶ್ಲೇಷಣೆ ಮತ್ತು ಮೌಲ್ಯಮಾಪನವನ್ನು ಒದಗಿಸುತ್ತೇವೆ.
ಉತ್ಪಾದನೆ
ಔಷಧೀಯ ಉತ್ಪನ್ನಗಳ ಸಾಮರ್ಥ್ಯವು ಟನ್ ದರ್ಜೆಯನ್ನು ತಲುಪಿದೆ, ರಾಸಾಯನಿಕ ಉತ್ಪನ್ನಗಳ ಸಾಮರ್ಥ್ಯವು 100 ಟನ್ಗಳಿಗಿಂತ ಹೆಚ್ಚು ದರ್ಜೆಯನ್ನು ತಲುಪಿದೆ, ವಿಶ್ವಾದ್ಯಂತ ಗ್ರಾಹಕರಿಗೆ ಸೇವೆ ಸಲ್ಲಿಸಲು ಸಾಮರ್ಥ್ಯಗಳು ಉತ್ತಮವಾಗಿ ಸಜ್ಜುಗೊಂಡಿವೆ.
ಸಂಶೋಧನೆ ಮತ್ತು ಅಭಿವೃದ್ಧಿ
ಪ್ರತಿ ವರ್ಷವೂ, ಸಂಶೋಧನೆ ಮತ್ತು ಅಭಿವೃದ್ಧಿ ತಂಡವು ವಿಭಿನ್ನ ಹೊಸ ಉತ್ಪನ್ನಗಳನ್ನು ಅಭಿವೃದ್ಧಿಪಡಿಸಲು ಯೋಜನೆಯನ್ನು ರೂಪಿಸುತ್ತದೆ, ಗುರಿಗಳನ್ನು ನಿಗದಿಪಡಿಸಿದಾಗ, ತಂಡದ ಪ್ರತಿಯೊಬ್ಬ ಸದಸ್ಯರು KPI ಜವಾಬ್ದಾರಿ ಮತ್ತು ಪ್ರೋತ್ಸಾಹಕ ನೀತಿಯೊಂದಿಗೆ ಮುಂದುವರಿಯಬೇಕಾಗುತ್ತದೆ.